Eliem Therapeutics begins trading on Nasdaq, raising $80M
August 10, 2021 at 17:25 PM EDT
The Redmond-based company joins a growing list of Seattle-area biotechs that have gone public in recent years, including Sana Biotechnology and Adaptive Biotechnologies.
